Subscribe

Dosing Palifermin (Kepivance) to Reduce Oral Mucositis Associated with Hematopoietic Stem Cell Transplant (HSCT)

Specialty:

Hematology Oncology
General Surgery
Clinical Pharmacology

Objective:

ICD-10:

Description:

Palifermin (Kepivance) can reduce the oral mucositis associated with chemoradiation in patients receiving a hematopoietic stem cell transplant (HSCT).

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone